Initial assessment for patients with HIV: Difference between revisions

From IDWiki
()
No edit summary
 
Line 30: Line 30:
 
**Rubella serology
 
**Rubella serology
 
**Trichomonas testing
 
**Trichomonas testing
  +
*Low threshold for CT chest/abdo/pelvis for lymphadenopathy and non-tuberculous mycobacteria in patients with low CD4 counts
   
  +
== Physical Examination ==
==Initial regimens==
 
  +
  +
* Assess for cutaneous Kaposi sarcoma
  +
 
==Initial Regimens==
   
 
*All are integrase inhibitor with two nucleoside analogues
 
*All are integrase inhibitor with two nucleoside analogues
 
*Consider one of the [[single-tablet regimens for HIV]]
 
*Consider one of the [[single-tablet regimens for HIV]]
  +
**Biktarvy 1 tablet PO once daily
 
**Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
 
**Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
 
**Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
 
**Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
 
**Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
 
**Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
 
**Complera: emtricitabine/rilpivirine/tenofovir disoproxil
 
**Complera: emtricitabine/rilpivirine/tenofovir disoproxil
  +
*Don't forget to add [[TMP-SMX]] DS 1 tablet PO daily if presumed low CD4 count
   
 
==Further Reading==
 
==Further Reading==

Latest revision as of 11:10, 30 April 2021

History

Investigations

  • HIV-specific
    • CD4/CD8 count
    • HIV-RNA viral load
    • HIV genotype
    • HLA *B5701 genotyping (for abacavir)
    • Genetic resistance assays (± tropism testing for CCR5 inhibitors)
    • G6PD deficiency
  • Routine
    • CBC, lytes, creatinine
    • Fasting lipids, Hb A1c
    • Urinalysis (glucose and protein)
    • Consider bone mineral density testing and vitamin D levels
  • STIs and coinfections
    • TB skin test
    • Consider chest x-ray
    • HAV-IgG, HBV-sAg/sAb/cAb, and HCV-Ab
    • Syphilis
    • Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
    • Toxoplasma, varicella, CMV, and measles serologies
  • For cis women and trans men
    • Pap smear
    • Rubella serology
    • Trichomonas testing
  • Low threshold for CT chest/abdo/pelvis for lymphadenopathy and non-tuberculous mycobacteria in patients with low CD4 counts

Physical Examination

  • Assess for cutaneous Kaposi sarcoma

Initial Regimens

  • All are integrase inhibitor with two nucleoside analogues
  • Consider one of the single-tablet regimens for HIV
    • Biktarvy 1 tablet PO once daily
    • Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
    • Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
    • Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
    • Complera: emtricitabine/rilpivirine/tenofovir disoproxil
  • Don't forget to add TMP-SMX DS 1 tablet PO daily if presumed low CD4 count

Further Reading